GPT and metabolic dysfunction-associated steatohepatitis: The aim of this study was to compare the performance of 2 new blood tests, NIS4® and NIS2+TM, with FIB-4, NFS, ELFTM, and alanine aminotransferase (ALT) for the diagnosis of at-risk NASH in a cohort of patients aged ≥65 years.